Page last updated: 2024-09-05

1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane and Cognition Disorders

1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane has been researched along with Cognition Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, L; He, Z; Huang, L; Wang, H; Wang, J; Wu, Y1

Other Studies

1 other study(ies) available for 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane and Cognition Disorders

ArticleYear
DDPH: improving cognitive deficits beyond its alpha 1-adrenoceptor antagonism in chronic cerebral hypoperfused rats.
    European journal of pharmacology, 2008, Jul-07, Volume: 588, Issue:2-3

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Blotting, Western; Brain Ischemia; Cerebrovascular Circulation; Chronic Disease; Cognition Disorders; Glutathione Peroxidase; Hippocampus; Long-Term Potentiation; Male; Malondialdehyde; Maze Learning; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Superoxide Dismutase

2008